Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Loss of heterozygosity (LOH) in chromosome region 6q27 and p53 mutations were studied to attempt to clarify the genetic etiology of ovarian cancer, with particular reference to clear cell adenocarcinoma (CCG), which has a poor prognosis. 6q27 LOH in 70 epithelial oyarian cancer patients was examined using four restriction fragment length polymorphism markers located at 6q27; p53 mutations in tumor DNA were detected using polymerase chain reaction singlestrand conformation polymorphism and sequencing. 6q27 LOH was confirmed in 26 of 48 informative cases (54.2%). No differences in the incidence of 6q27 LOH were seen by histologic type; 6q27 LOH was observed in 45% (5/11) of CCCs. p53 mutations were detected in 19 of the 48 tumors (39.6%), but in only one (9%) CCC. These results suggest that a putative tumor suppressor gene involved in the onset of epithelial ovarian cancer is located at 6q27. This gene is one of the keys to clarifying the genetic etiology of epithelial ovarian cancer and particularly CCC, given the low incidence of p53 mutations in this tumor type.
- Bertelsen Ket al. A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian cancer.Gynecol Oncol 1987;28: 161–169. CrossRef
- Ministry of Health and Welfare of Japan. Changes in mortality rate of major malignant tumors by organ. In:Annual Reporc on Health and Welfare, 1997: Vital Statistics. Ministry of Health and Welfare; Tokyo; 1997.
- Okamoto Aet al. Frequent altelic losses and mutations of the p53 gene in human ovarian cancer.Cancer Res 1991;51: 5171–5176.
- Fujita Met at. Alteration of the p53 tumor suppresser gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.Jpn J Cancer Res 1994;85: 1247–1256.
- Niwa Ket al. Alteration of p53 gene in ovarian carcinoma: ClinicopatholoNcal correlation and prognostic significance.Br J Cancer 1994;70: 1191–1197.
- Mazars R, Pujol R, Maudelonde T, Jeanteur R Theitlet p53 mutations in ovarian cancer: A late event?Oncogene 1991;6: 1685–1690.
- Milner BJet al. p53 mutation is a common genetic event in ovarian carcinoma.Cancer Res 1993;53: 2128–2132.
- Wertheim Iet al. p53 gene mutation in human borderline epithelial ovarian tumors. JNatl Cancer Inst 1994;86: 1549–1551. CrossRef
- Kim JWet al. Aberration of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.Gynecol Oncol 1995;57: 199–204. CrossRef
- Ehlen T, Dubeau L. Loss of heterozygosity on chromosomal segments 3p, 6q and llp in human ovarian carcinomas.Oncogene 1990;5: 219–223.
- Lee JH, Kavanagh JJ, Wildrik DM, Wharton JT, Blick M. Frequent toss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.Cancer Res 1990;50: 2724–2728.
- Sato Tet al. Alletotype of human ovarian cancer.Cancer Res 1991;51: 5118–5122.
- Zheng J, Robinson WR, Ehlen T, Yu MC, Dubeau L. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/new gene amplification.Cancer Res 1991;51: 4045–4051.
- Saito Set al. Fine-scale deletion mapping of the distal long arm chromosome 6 in 70 human ovarian cancers.Cancer Res 1992;52: 5815–5817.
- Cliby Wet al. Human epithelial ovarian cancer allelotype.Cancer Res 1993;53: 2393–2398.
- Foulkes WD, Ragoussis J, Stamp GWH, Allan GJ, Trowsdale X Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.BrJ Cancer 1993;67: 551–559.
- Wan Met al. Three distinct regions of chromosome 6 are targets of loss of heterozygosity in human ovarian carcinomas.Int J Oncol 1994;5: 1043–1048.
- Orphanos Vet al. Allelic imbalance of chromosome 6q in ovarian tumours.Br J Cancer 1995;71: 666–669.
- Cooke IE, Shelling AN, Meuth VGL, Charnock FML, Ganesan TS. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer,Genes Chromosomes Cancer 1996;15: 223–233. CrossRef
- Saito Set al. Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27.Cancer Res 1996;56: 5586–5589.
- Montag AGet al. Ovarian clear cell carcinoma.Int J Gynecol Pathol 1989;8: 85–96. CrossRef
- Jenison ELet al. Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma.Gynecol Oncol 1989;32: 65–71. CrossRef
- Omura GAet al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience. JClin OncoI 1991;9: 1138–1150.
- Sato Tet al. Allelotype of breast cancer: Cumulative allele losses promote tumor progression in primary breast cancer.Cancer Res 1990;50: 7184–7189.
- Hsu ICet al. Mutational hotshot in the p53 gene in human hepatocellular carcinomas.Nature 1991;350: 427–428. CrossRef
- Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.Cancer Res 1991;51: 5520–5525.
- Shelling AN, Cooke IE, Ganesan TS. The genetic analysis of ovarian cancer.Br J Cancer 1995;72: 521–527.
- Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer
Volume 15, Issue 2 , pp 119-123
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press
- Additional Links
- loss of heterozygosity
- ovarian cancer
- clear cell adenocarcinoma
- Industry Sectors